Annual Retained Earnings
-$244.76 M
-$100.16 M-69.27%
December 31, 2023
Summary
- As of February 7, 2025, EWTX annual retained earnings is -$244.76 million, with the most recent change of -$100.16 million (-69.27%) on December 31, 2023.
- During the last 3 years, EWTX annual retained earnings has fallen by -$210.62 million (-616.79%).
- EWTX annual retained earnings is now -1337.75% below its all-time high of -$17.02 million, reached on December 31, 2019.
Performance
EWTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$338.91 M
-$34.13 M-11.20%
September 30, 2024
Summary
- As of February 7, 2025, EWTX quarterly retained earnings is -$338.91 million, with the most recent change of -$34.13 million (-11.20%) on September 30, 2024.
- Over the past year, EWTX quarterly retained earnings has dropped by -$124.29 million (-57.91%).
- EWTX quarterly retained earnings is now -892.51% below its all-time high of -$34.15 million, reached on December 31, 2020.
Performance
EWTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
EWTX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -69.3% | -57.9% |
| 3 y3 years | -616.8% | -57.9% |
| 5 y5 years | -1337.8% | -57.9% |
EWTX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -218.0% | at low | -340.4% | at low |
| 5 y | 5-year | -1337.8% | at low | -892.5% | at low |
| alltime | all time | -1337.8% | at low | -892.5% | at low |
Edgewise Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$338.91 M(+11.2%) |
| Jun 2024 | - | -$304.79 M(+11.5%) |
| Mar 2024 | - | -$273.29 M(+11.7%) |
| Dec 2023 | -$244.76 M(+69.3%) | -$244.76 M(+14.0%) |
| Sep 2023 | - | -$214.62 M(+13.6%) |
| Jun 2023 | - | -$188.91 M(+12.8%) |
| Mar 2023 | - | -$167.44 M(+15.8%) |
| Dec 2022 | -$144.60 M | -$144.60 M(+15.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$125.19 M(+16.2%) |
| Jun 2022 | - | -$107.69 M(+17.5%) |
| Mar 2022 | - | -$91.62 M(+19.0%) |
| Dec 2021 | -$76.96 M(+125.4%) | -$76.96 M(+19.8%) |
| Sep 2021 | - | -$64.26 M(+25.2%) |
| Jun 2021 | - | -$51.31 M(+25.3%) |
| Mar 2021 | - | -$40.96 M(+20.0%) |
| Dec 2020 | -$34.15 M(+100.6%) | -$34.15 M |
| Dec 2019 | -$17.02 M | - |
FAQ
- What is Edgewise Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual retained earnings year-on-year change?
- What is Edgewise Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly retained earnings year-on-year change?
What is Edgewise Therapeutics annual retained earnings?
The current annual retained earnings of EWTX is -$244.76 M
What is the all time high annual retained earnings for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual retained earnings is -$17.02 M
What is Edgewise Therapeutics annual retained earnings year-on-year change?
Over the past year, EWTX annual retained earnings has changed by -$100.16 M (-69.27%)
What is Edgewise Therapeutics quarterly retained earnings?
The current quarterly retained earnings of EWTX is -$338.91 M
What is the all time high quarterly retained earnings for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly retained earnings is -$34.15 M
What is Edgewise Therapeutics quarterly retained earnings year-on-year change?
Over the past year, EWTX quarterly retained earnings has changed by -$124.29 M (-57.91%)